Blog

Posted on January 10, 2019 by Marty Aisenberg

620 cases claiming that glyphosate (the active ingredient in Monsanto’s Roundup weed killer) causes cancer are pending in the U.S. District Court for the Northern District of California.

Posted on January 8, 2019 by Peter George

As an expert witness referral service, we provide experts in all fields of specialization for all types of litigation.  One of the core areas of litigation that we are involved with is medical malpractice.

Posted on January 3, 2019 by Marty Aisenberg

An important question in medical malpractice cases is whether the plaintiff’s standard of care expert must be board certified in the same specialty as the defendant, or must at least practice in the same area of specialization without board certification.  Many states have enacted controlling statutes on this issue.  If the answer to the “same specialty” question is yes, the plaintiff frequently needs two experts – one to opine on the standard of care, and one to address causation.  In a 2018 case, the South Carolina Supreme Court carefully construed the relevant statute and held that, unde

Posted on December 20, 2018 by Marty Aisenberg

Hartung Commercial Properties v. Buffi’s Automotive Equipment and Supply (Ala.

Posted on December 13, 2018 by Marty Aisenberg

The case is Smith v. Chrysler Group (5th Cir. 11/26/2018), http://www.ca5.uscourts.gov/opinions/pub/17/17-40901-CV0.pdf.   The opinion concisely summarizes the facts as follows:

Posted on December 10, 2018 by Marty Aisenberg

Many states require the plaintiff’s expert in a medical malpractice case to be board certified in the same specialty as the defendant.  The dire consequence of an attorney’s failure to meet this requirement precisely was recently demonstrated in Shadrick v. Grana (https://acis.alabama.gov/displaydocs.cfm?no=907441&event=5BT0M4P9Y).

Categories

ACA
FDA
Vident
2023 © Vident Partners.